[{"quiz_id": "ABMS20260101_claude-opus-4-5-20251101_p02", "question_id": "ABMS20260101_claude-opus-4-5-20251101_p02-001", "question": "A 52-year-old woman with a 15-year history of dermatomyositis presents with a new 2.5 cm erythematous, indurated plaque on her left thigh that has been present for 8 months. Biopsy reveals atypical lymphoid infiltrate with CD4+, CD8-, and loss of CD7 expression. TCR gene rearrangement studies demonstrate a monoclonal population. PET-CT shows no evidence of systemic disease. Which statement regarding this patient's condition is MOST accurate?", "options": ["This represents transformation of dermatomyositis to systemic T-cell lymphoma requiring CHOP chemotherapy", "This is a primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder with excellent prognosis", "The dermatomyositis was likely a paraneoplastic phenomenon of an underlying T-cell lymphoma", "This represents mycosis fungoides arising in the setting of chronic inflammation requiring total skin electron beam therapy", "Immediate allogeneic stem cell transplantation is indicated given the immunocompromised state"], "answer": "B", "answer_index": 1, "explanation": "Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder (PC-SMLPD) is a provisional entity in the WHO classification characterized by solitary or localized lesions with CD4+CD8- phenotype and clonal TCR rearrangement. Despite the alarming histopathology, it has an indolent course with excellent prognosis (>95% 5-year survival) and is typically managed with local therapy alone. This is distinct from systemic T-cell lymphomas and mycosis fungoides, which have different clinical presentations and prognoses.", "generator_model": "claude-opus-4-5-20251101", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Dermatology", "abms_specialty": "Dermatology", "abms_source": "target_topic", "source_label_raw": "Dermatology", "source_quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129", "source_question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129-002", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/claude-opus-4-5-20251101/20251218T014545383Z_claude-opus-4-5-20251101_seed129", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251218T014545383Z_claude-opus-4-5-20251101_seed129.jsonl", "pred": "B", "model_outputs": "This question describes a patient with a solitary cutaneous lesion showing an atypical lymphoid infiltrate of CD4+ T-cells with loss of CD7 (a common aberrant phenotype) and monoclonal TCR gene rearrangement, in the absence of systemic disease.\n\n1.  Diagnosis: The clinical presentation of a solitary plaque or nodule (often on the head/neck, but can occur elsewhere) combined with the histopathologic findings of a dense infiltrate of small-to-medium-sized pleomorphic CD4+ T-cells fits the diagnosis of Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorder (PCSM-TCLPD).\n2.  Classification History: In previous classifications, this might have been termed a \"lymphoma,\" but the 2016 WHO classification (and subsequent updates) designated it a \"lymphoproliferative disorder\" to emphasize its indolent clinical behavior and prevent overtreatment.\n3.  Prognosis and Treatment: This condition has an excellent prognosis. The lesions are typically localized and respond well to conservative management such as surgical excision, intralesional steroids, or localized radiation therapy. Systemic chemotherapy (like CHOP) or aggressive interventions (like stem cell transplant) are not indicated.\n4.  Differential:\n    *   Mycosis Fungoides (MF) typically presents with patches and plaques, often multiple, and has distinct histologic features (epidermotropism). Total skin electron beam therapy is used for widespread disease, not a solitary lesion.\n    *   Systemic Lymphoma: The negative PET-CT rules out systemic involvement, making transformation or systemic lymphoma less likely.\n    *   Paraneoplastic Dermatomyositis: While dermatomyositis is associated with internal malignancy, the 15-year history predating the lesion makes it unlikely that the dermatomyositis was a paraneoplastic sign of this *specific* new skin lesion. Furthermore, PCSM-TCLPD is an indolent cutaneous entity, not the type of aggressive systemic malignancy typically associated with paraneoplastic dermatomyositis.\n\nTherefore, the most accurate statement describes the specific entity and its favorable prognosis.\n\nThe answer is (B)"}, {"quiz_id": "ABMS20260101_claude-opus-4-5-20251101_p02", "question_id": "ABMS20260101_claude-opus-4-5-20251101_p02-002", "question": "A 67-year-old man undergoes robot-assisted radical prostatectomy for Gleason 4+3=7 prostate cancer. Final pathology reveals pT3aN0 disease with positive surgical margins at the apex. PSA at 6 weeks is undetectable. At 18 months, PSA rises to 0.35 ng/mL. PSMA-PET scan shows a single 8mm focus of uptake in the right obturator lymph node with SUVmax of 12. No other sites of disease are identified. Which management strategy offers the BEST oncologic outcome based on current evidence?", "options": ["Observation with serial PSA monitoring until symptomatic progression", "Androgen deprivation therapy alone for 24 months", "Salvage radiation therapy to the prostate bed alone (66-70 Gy)", "Salvage radiation therapy to prostate bed plus elective nodal irradiation with short-term ADT", "Stereotactic body radiation therapy to the PSMA-avid lymph node alone"], "answer": "D", "answer_index": 3, "explanation": "The SPPORT trial and subsequent analyses demonstrate that for biochemical recurrence after prostatectomy, salvage radiation to the prostate bed combined with pelvic lymph node irradiation and short-term ADT (4-6 months) provides superior freedom from progression compared to prostate bed radiation alone. While SBRT to oligometastatic disease is emerging, current evidence supports comprehensive salvage therapy. The PSMA-PET finding of nodal disease supports inclusion of elective nodal fields, as micrometastatic disease beyond the visible lesion is likely present.", "generator_model": "claude-opus-4-5-20251101", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Urology", "abms_specialty": "Urology", "abms_source": "target_topic", "source_label_raw": "Urology", "source_quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129", "source_question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129-003", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/claude-opus-4-5-20251101/20251218T014545383Z_claude-opus-4-5-20251101_seed129", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251218T014545383Z_claude-opus-4-5-20251101_seed129.jsonl", "pred": "D", "model_outputs": "The patient presents with biochemical recurrence after radical prostatectomy, and PSMA-PET imaging identifies a single recurrence in a pelvic lymph node (oligorecurrent nodal disease).\n\nThe management of patients with nodal recurrence after prostatectomy has evolved. Based on the SPPORT trial (RTOG 0534), published in *The Lancet* (2022), the addition of short-term androgen deprivation therapy (ADT) and pelvic lymph node radiotherapy to salvage prostate bed radiotherapy showed superior progression-free survival compared to prostate bed radiotherapy alone or prostate bed radiotherapy with ADT.\n\nWhile the patient has a distinct PSMA-avid node, treating only that node (Option E, metastasis-directed therapy via SBRT) is associated with a higher risk of regional recurrence in adjacent untreated lymph nodes compared to elective nodal irradiation. The \"best oncologic outcome\" in terms of maximizing disease control and progression-free survival is achieved by treating the prostate bed (site of positive margins/potential microscopic disease), the pelvic lymph nodes (site of macroscopic recurrence and potential microscopic spread), and using systemic ADT.\n\nTherefore, the comprehensive approach of salvage radiation to the prostate bed and pelvic lymph nodes with short-term ADT is the most evidence-based strategy for durable control.\n\nThe answer is (D)"}, {"quiz_id": "ABMS20260101_claude-opus-4-5-20251101_p02", "question_id": "ABMS20260101_claude-opus-4-5-20251101_p02-003", "question": "A 58-year-old man presents with progressive dysphagia to solids over 6 months and a 15-pound weight loss. He has a 40-pack-year smoking history. Flexible laryngoscopy reveals a fungating mass involving the right pyriform sinus with extension to the postcricoid region and fixation of the right vocal cord. CT shows a 4.2 cm mass with cartilage invasion and two ipsilateral lymph nodes measuring 2.1 cm and 1.8 cm. PET-CT shows no distant metastases. What is the MOST appropriate initial management?", "options": ["Total laryngopharyngectomy with bilateral neck dissection and free flap reconstruction", "Definitive chemoradiation with cisplatin-based concurrent chemotherapy", "Induction chemotherapy with TPF followed by chemoradiation for responders", "Transoral robotic surgery with adjuvant radiation therapy", "Larynx-preservation protocol with carboplatin/paclitaxel and radiation"], "answer": "A", "answer_index": 0, "explanation": "This patient has a T4a (cartilage invasion) hypopharyngeal squamous cell carcinoma with N2b nodal disease. Hypopharyngeal cancers, particularly those involving the postcricoid region with cartilage invasion and vocal cord fixation, have poor outcomes with organ preservation approaches compared to laryngeal primaries. The RTOG 91-11 larynx preservation data does not apply to hypopharyngeal cancers. For T4a hypopharyngeal cancer with cartilage invasion, primary surgical resection with total laryngopharyngectomy, bilateral neck dissection, and reconstruction followed by adjuvant therapy offers the best oncologic outcome.", "generator_model": "claude-opus-4-5-20251101", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Otolaryngology", "abms_specialty": "Otolaryngology", "abms_source": "target_topic", "source_label_raw": "Otolaryngology", "source_quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129", "source_question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129-004", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/claude-opus-4-5-20251101/20251218T014545383Z_claude-opus-4-5-20251101_seed129", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251218T014545383Z_claude-opus-4-5-20251101_seed129.jsonl", "pred": "A", "model_outputs": "The patient presents with a T4aN2M0 (Stage IVa) squamous cell carcinoma of the hypopharynx involving the right pyriform sinus. The key staging features are the fixation of the vocal cord and, crucially, cartilage invasion by a 4.2 cm mass.\n\nWhile organ preservation strategies (concurrent chemoradiation or induction chemotherapy) are standard for T2 and T3 tumors (and selected low-volume T4 tumors), T4a tumors with frank cartilage invasion generally respond poorly to radiation-based organ preservation. In these cases, chemoradiation is associated with lower rates of local control and survival compared to surgery. Furthermore, irradiation of invaded cartilage carries a high risk of chondroradionecrosis and leaves the patient with a dysfunctional, often painful, and aspirating larynx.\n\nTherefore, the consensus and guidelines (e.g., NCCN) usually recommend surgical resection for T4a hypopharyngeal cancer with extensive cartilage destruction/invasion to maximize oncologic control. The procedure involves removing the larynx and pharynx (total laryngopharyngectomy), addressing the lymph nodes (bilateral neck dissection is standard for hypopharynx due to the high risk of contralateral metastasis), and reconstructing the pharyngeal defect (usually with a free flap like a radial forearm or anterolateral thigh flap).\n\nOption B (Definitive chemoradiation) is less appropriate locally for T4a disease with cartilage invasion.\nOption C (Induction chemotherapy) is a strategy for organ preservation, which is generally not the goal when the organ is already structurally compromised by cartilage invasion.\nOption D (TORS) is not indicated for T4 invasive disease.\nOption E represents a larynx-preservation protocol, which is suboptimal for the reasons stated above, and carboplatin/paclitaxel is typically reserved for cisplatin-ineligible patients.\n\nThe answer is (A)"}, {"quiz_id": "ABMS20260101_claude-opus-4-5-20251101_p02", "question_id": "ABMS20260101_claude-opus-4-5-20251101_p02-004", "question": "A 42-year-old woman with multiple sclerosis presents for evaluation of neurogenic bladder. Urodynamic studies reveal detrusor overactivity with detrusor-sphincter dyssynergia, maximum detrusor pressure of 65 cmH2O during involuntary contractions, and post-void residual of 280 mL. She has been performing clean intermittent catheterization 4 times daily and taking oxybutynin 5mg TID with inadequate symptom control and intolerable anticholinergic side effects. Renal ultrasound shows mild bilateral hydronephrosis. Which intervention provides the MOST durable improvement in upper tract protection while maintaining quality of life?", "options": ["Increase anticholinergic dose with addition of mirabegron", "Sacral neuromodulation with InterStim device", "Intradetrusor onabotulinumtoxinA injection 200 units", "Augmentation cystoplasty with continent catheterizable channel", "Sphincterotomy with condom catheter drainage"], "answer": "C", "answer_index": 2, "explanation": "For neurogenic detrusor overactivity with detrusor-sphincter dyssynergia refractory to oral anticholinergics, intradetrusor onabotulinumtoxinA injection (200 units for neurogenic bladder) provides effective reduction in detrusor pressures and protection of the upper tracts while maintaining continence with CIC. It has Level A evidence for neurogenic bladder. Sacral neuromodulation has limited efficacy in complete neurogenic bladder. Augmentation cystoplasty is more invasive and reserved for refractory cases. Sphincterotomy would eliminate continence. The mild hydronephrosis indicates need for intervention to reduce storage pressures.", "generator_model": "claude-opus-4-5-20251101", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Physical Medicine and Rehabilitation", "abms_specialty": "Physical Medicine and Rehabilitation", "abms_source": "target_topic", "source_label_raw": "Physical Medicine and Rehabilitation", "source_quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129", "source_question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129-005", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/claude-opus-4-5-20251101/20251218T014545383Z_claude-opus-4-5-20251101_seed129", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251218T014545383Z_claude-opus-4-5-20251101_seed129.jsonl", "pred": "C", "model_outputs": "The patient is a 42-year-old woman with multiple sclerosis and a neurogenic bladder characterized by detrusor overactivity (DO) and detrusor-sphincter dyssynergia (DSD). Urodynamics show dangerous storage pressures (65 cmH2O), which places her at high risk for upper urinary tract deterioration, evidenced by the mild hydronephrosis. She has failed anticholinergic therapy (inadequate control and intolerable side effects).\n\nWe must choose the best intervention for renal preservation and quality of life (QoL).\n\n1.  Analyze Option A (Increase anticholinergic dose...): Since the patient already has intolerable side effects, increasing the dose is contraindicated, regardless of adding mirabegron. This would worsen her QoL.\n2.  Analyze Option B (Sacral neuromodulation): While SNM can be used in minimal MS, it is generally less effective in patients with DSD and advanced neurogenic bladder features. Furthermore, the need for future MRIs in an MS patient (though newer devices are MRI-conditional) and the progressive nature of the disease make this less favorable than other options for immediate and robust pressure reduction to protect the kidneys.\n3.  Analyze Option C (Intradetrusor onabotulinumtoxinA injection 200 units): According to AUA/SUFU guidelines, onabotulinumtoxinA (Botox) is the standard third-line treatment for neurogenic detrusor overactivity after failure of oral medications. The 200-unit dose is the FDA-approved specific dose for neurogenic bladder (vs. 100 units for non-neurogenic OAB). Botox effectively paralyzes the detrusor muscle, lowering storage pressures significantly (<40 cmH2O), which resolves the hydronephrosis and incontinence. Since the patient is already performing Clean Intermittent Catheterization (CIC), the primary side effect of Botox (urinary retention) is already being managed. It offers durable protection of the upper tracts with repeat injections and avoids the morbidity of major reconstructive surgery.\n4.  Analyze Option D (Augmentation cystoplasty): This is a major surgery generally reserved for patients who have failed or cannot tolerate Botox. While it provides a \"permanent\" solution to pressure, it carries significant long-term risks (mucus production, stones, metabolic acidosis, rupture, malignancy) and prolonged recovery. It is not the \"single best option\" before trying less invasive, highly effective therapies like Botox.\n5.  Analyze Option E (Sphincterotomy with condom catheter): Sphincterotomy ablates the sphincter to allow continuous low-pressure drainage. This is typically utilized in male patients who can wear a condom catheter to manage the resulting continuous incontinence. For a female, this would result in unmanageable continuous incontinence requiring diapers, causing skin breakdown and severe loss of QoL.\n\nTherefore, Intradetrusor onabotulinumtoxinA is the most appropriate next step in management.\n\nThe answer is (C)"}, {"quiz_id": "ABMS20260101_claude-opus-4-5-20251101_p02", "question_id": "ABMS20260101_claude-opus-4-5-20251101_p02-005", "question": "A 28-year-old woman undergoes deep inferior epigastric perforator (DIEP) flap breast reconstruction following mastectomy. On postoperative day 1, the flap appears congested with rapid capillary refill, dark purple color, and brisk dark bleeding on pinprick. Doppler signals show arterial inflow but absent venous outflow. Immediate surgical exploration reveals thrombosis of the venous anastomosis. After successful thrombectomy and revision of the anastomosis, which adjunctive measure has the STRONGEST evidence for improving flap salvage in this scenario?", "options": ["Systemic heparinization with aPTT goal 60-80 seconds", "Application of medicinal leeches to the flap surface", "Topical nitroglycerin paste to the flap skin paddle", "Hyperbaric oxygen therapy at 2.4 ATA for 90 minutes daily", "Intravenous dextran-40 infusion at 25 mL/hour"], "answer": "B", "answer_index": 1, "explanation": "Medicinal leeches (Hirudo medicinalis) provide the most effective adjunctive treatment for venous congestion in free flaps after surgical revision. Leeches provide passive bleeding that decompresses the congested flap while their saliva contains hirudin (anticoagulant), hyaluronidase, and vasodilators that promote continued bleeding after detachment. This allows time for neovascularization. Systemic heparinization increases bleeding risk without addressing the mechanical congestion. Dextran-40 has fallen out of favor due to bleeding complications and anaphylaxis risk. Hyperbaric oxygen and topical nitroglycerin have limited evidence for acute venous congestion.", "generator_model": "claude-opus-4-5-20251101", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Plastic Surgery", "abms_specialty": "Plastic Surgery", "abms_source": "target_topic", "source_label_raw": "Plastic Surgery", "source_quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129", "source_question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129-006", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/claude-opus-4-5-20251101/20251218T014545383Z_claude-opus-4-5-20251101_seed129", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251218T014545383Z_claude-opus-4-5-20251101_seed129.jsonl", "pred": "A", "model_outputs": "The scenario describes a DIEP flap that developed venous congestion due to venous thrombosis. The patient underwent successful surgical exploration, thrombectomy, and revision of the anastomosis. The question asks for the adjunctive measure with the strongest evidence for improving flap salvage in this specific post-revision context.\n\n1.  Surgical Revision is the Gold Standard: The primary treatment for anastomotic thrombosis is immediate surgical exploration and revision, which has already been performed.\n2.  Post-Salvage Pathophysiology: After thrombectomy and revision, the vessel endothelium is damaged, and the patient has demonstrated a propensity for clotting at that site. The risk of re-thrombosis is high.\n3.  Systemic Heparinization (Option A): Therapeutic anticoagulation with unfractionated heparin (targeting a specific aPTT, often 1.5-2x normal or 60-80 seconds) is the widely accepted standard of care following microsurgical flap salvage. It directly inhibits the coagulation cascade to prevent the propagation of new clots at the site of intimal injury. While high-level randomized control trials are rare in microsurgery, consensus guidelines and retrospective reviews consistently support the use of systemic heparin in the salvage setting to maintain patency.\n4.  Medicinal Leeches (Option B): Leeches are indicated for venous congestion that cannot be surgically corrected (e.g., inadequate intrinsic venous outflow or failure of the venous anastomosis revision). Since the prompt states the anastomosis was successfully revised and flow restored, leeches are not the primary indication. They address congestion, not the prevention of re-thrombosis at the main pedicle.\n5.  Intravenous Dextran-40 (Option E): Dextran acts as a volume expander and reduces blood viscosity and platelet aggregation. Historically, it was a common prophylactic agent. However, its use has declined due to the risk of serious complications (anaphylaxis, pulmonary edema, renal failure) and lack of clear evidence superior to other agents like aspirin or heparin. In the setting of *active* thrombosis and salvage, heparin is generally preferred over Dextran for its potent anticoagulant properties.\n6.  Other Options: Topical nitroglycerin (C) is a vasodilator used for arterial spasm or skin ischemia, not central venous thrombosis. Hyperbaric oxygen (D) is used for ischemia-reperfusion injury or questionable viability but does not prevent anastomotic re-thrombosis.\n\nTherefore, systemic heparinization is the most appropriate and evidence-supported adjunct to prevent re-thrombosis after a successful venous salvage procedure.\n\nThe answer is (A)"}, {"quiz_id": "ABMS20260101_claude-opus-4-5-20251101_p02", "question_id": "ABMS20260101_claude-opus-4-5-20251101_p02-006", "question": "A 45-year-old woman presents with a 6-month history of progressive right arm weakness and numbness. MRI of the cervical spine reveals a 2.8 cm intradural extramedullary mass at C5-C6 with homogeneous enhancement, located lateral to the spinal cord with extension through the neural foramen. The mass has a characteristic dumbbell shape. Preoperative angiography shows the tumor is supplied by branches of the vertebral artery. Which surgical approach provides optimal tumor resection while minimizing risk of spinal instability?", "options": ["Posterior laminectomy with tumor resection and instrumented fusion", "Anterior corpectomy with tumor resection and cage reconstruction", "Combined posterior laminectomy and anterior corpectomy in staged procedures", "Posterior laminoplasty with tumor resection preserving facet joints", "Posterolateral approach with hemilaminectomy and partial facetectomy"], "answer": "E", "answer_index": 4, "explanation": "Dumbbell-shaped schwannomas with foraminal extension are optimally approached via a posterolateral approach with hemilaminectomy and partial facetectomy, which provides adequate exposure of both intraspinal and extraforaminal components while preserving contralateral posterior elements and minimizing destabilization. Complete laminectomy with bilateral facet disruption significantly increases instability risk requiring fusion. The anterior approach provides poor access to the intradural component. Laminoplasty is designed for multilevel stenosis, not tumor resection. Staged procedures add morbidity without benefit for this tumor configuration.", "generator_model": "claude-opus-4-5-20251101", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurological Surgery", "abms_specialty": "Neurological Surgery", "abms_source": "target_topic", "source_label_raw": "Neurological Surgery", "source_quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129", "source_question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129-007", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/claude-opus-4-5-20251101/20251218T014545383Z_claude-opus-4-5-20251101_seed129", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251218T014545383Z_claude-opus-4-5-20251101_seed129.jsonl", "pred": "E", "model_outputs": "This clinical scenario describes a patient with a cervical dumbbell-shaped tumor, likely a schwannoma or neurofibroma, at the C5-C6 level. The tumor has both intradural and foraminal components. The \"dumbbell\" shape indicates it traverses the neural foramen.\n\nThe surgical goal is gross total resection while maintaining the biomechanical stability of the cervical spine.\n\n1.  Surgical Approach: Dumbbell tumors in the cervical spine are most commonly approached posteriorly. Anterior approaches (like corpectomy, Option B) are generally reserved for lesions that are primarily located within the vertebral body or strictly anterior to the spinal cord, and they are significantly more destabilizing and morbid for a laterally located tumor.\n2.  Laminectomy vs. Hemilaminectomy: A standard total laminectomy (Option A) involves removing the spinous processes, interspinous ligaments, and bilateral laminae. This disrupts the posterior tension band and carries a significant risk of post-laminectomy kyphosis (instability), particularly in the cervical spine. While instrumented fusion corrects this risk, it introduces the morbidity of fusion (loss of range of motion, adjacent segment disease).\n3.  Facet Management: To access the foraminal extension of the tumor, bone overlying the foramen (the facet joint) must be removed. Extensive (total) facetectomy causes rotational and translational instability and mandates fusion. However, for many dumbbell tumors, adequate exposure can be achieved with a partial facetectomy (removing less than 50% of the facet).\n4.  Optimal Strategy: A posterolateral approach utilizing a hemilaminectomy and partial facetectomy (Option E) is the preferred technique for resecting lateralized intradural-extramedullary tumors with foraminal extension. By preserving the midline structures (spinous process, interspinous ligaments) and the contralateral facet/lamina, the risk of post-operative spinal instability is minimized. This approach usually creates sufficient window to resect a 2.8 cm tumor without necessitating instrumented fusion.\n\nTherefore, Option E represents the approach that best balances optimal resection with the preservation of native spinal stability.\n\nThe answer is (E)"}, {"quiz_id": "ABMS20260101_claude-opus-4-5-20251101_p02", "question_id": "ABMS20260101_claude-opus-4-5-20251101_p02-007", "question": "A 68-year-old man with HPV-positive oropharyngeal squamous cell carcinoma (T2N1M0, p16+) is treated with definitive intensity-modulated radiation therapy (70 Gy in 35 fractions) with concurrent cisplatin. At 3-month follow-up, PET-CT shows complete metabolic response. At 18 months, he develops progressive dysphagia and weight loss. Modified barium swallow reveals severe pharyngeal dysmotility with aspiration. Direct laryngoscopy shows no tumor recurrence but severe pharyngeal fibrosis with reduced epiglottic deflection. Which factor during his initial treatment MOST strongly predicts this complication?", "options": ["Mean dose to the superior pharyngeal constrictor muscle >60 Gy", "Maximum dose to the larynx >70 Gy", "Mean dose to the parotid glands >26 Gy", "Volume of oral cavity receiving >40 Gy", "Mean dose to the cervical esophagus >45 Gy"], "answer": "A", "answer_index": 0, "explanation": "Severe late dysphagia with pharyngeal dysmotility following head and neck radiation is most strongly associated with dose to the pharyngeal constrictor muscles, particularly the superior and middle constrictors. The QUANTEC guidelines and subsequent studies identify mean pharyngeal constrictor dose >60 Gy as a significant predictor of severe dysphagia. Modern IMRT planning prioritizes constrictor sparing when oncologically feasible. While laryngeal dose affects aspiration risk and parotid dose affects xerostomia, the described pattern of pharyngeal dysmotility with reduced epiglottic deflection specifically implicates constrictor muscle fibrosis. Esophageal dose correlates more with stricture than dysmotility.", "generator_model": "claude-opus-4-5-20251101", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Radiation Oncology", "abms_specialty": "Radiation Oncology", "abms_source": "target_topic", "source_label_raw": "Radiation Oncology", "source_quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129", "source_question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129-018", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/claude-opus-4-5-20251101/20251218T014545383Z_claude-opus-4-5-20251101_seed129", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251218T014545383Z_claude-opus-4-5-20251101_seed129.jsonl", "pred": "A", "model_outputs": "The clinical presentation describes late radiation-associated dysphagia (RAD) characterized by fibrosis, pharyngeal dysmotility, and aspiration. This condition is distinct from recurrence or esophageal stricture. The structures most critical to the development of this type of dysphagia are the dysphagia/aspiration-related structures (DARS), specifically the pharyngeal constrictor muscles (superior, middle, inferior) and the supraglottic larynx.\n\nNumerous studies (e.g., by Feng, Christianen, Levendag) have demonstrated a strong dose-volume relationship between the radiation dose delivered to the pharyngeal constrictor muscles and long-term swallowing function. In patients with oropharyngeal carcinoma, the superior pharyngeal constrictor (SPC) is often in close proximity to the high-dose target volumes.\n\nSpecifically, a mean dose to the pharyngeal constrictors (especially the superior and middle constrictors in oropharyngeal cases) exceeding 50-60 Gy is a robust predictor of late dysphagia and aspiration. Constraints typically recommend keeping the mean dose to the pharyngeal constrictors below 50-55 Gy to minimize this risk.\n\nWhile the parotid dose (Option C) predicts xerostomia, and oral cavity dose (Option D) predicts mucositis/oral phase difficulties, neither accounts for severe pharyngeal dysmotility. High laryngeal doses (Option B) contribute to edema and aspiration risk, but the specific \"pharyngeal dysmotility\" and fibrosis described are conceptually and empirically linked most strongly to the dose received by the pharyngeal musculature.\n\nThe answer is (A)\n\nThe answer is A"}, {"quiz_id": "ABMS20260101_claude-opus-4-5-20251101_p02", "question_id": "ABMS20260101_claude-opus-4-5-20251101_p02-008", "question": "A 71-year-old man undergoes right pneumonectomy for centrally located squamous cell carcinoma. On postoperative day 8, he develops sudden onset of copious purulent sputum production, fever, and respiratory distress. Bronchoscopy reveals a 1.5 cm dehiscence of the bronchial stump with visible empyema cavity. The patient is hemodynamically stable after fluid resuscitation. Which management strategy is MOST appropriate?", "options": ["Immediate completion thoracoplasty with muscle flap coverage", "Open window thoracostomy (Eloesser flap) with delayed stump repair", "Endoscopic stump closure with fibrin glue and covered stent placement", "Chest tube drainage with broad-spectrum antibiotics and observation", "Transsternal transpericardial bronchial stump re-closure"], "answer": "B", "answer_index": 1, "explanation": "Post-pneumonectomy bronchopleural fistula (BPF) with empyema is a life-threatening complication requiring staged management. The initial priority is source control and drainage. Open window thoracostomy (Eloesser flap or Clagett procedure) provides dependent drainage, allows cavity sterilization, and converts the contaminated space to a controlled environment. Once the cavity is clean and granulating (typically 6-8 weeks), delayed closure with muscle flap transposition can be performed. Immediate thoracoplasty in an infected field has high failure rates. Endoscopic approaches are for small fistulas without empyema. Transsternal approach is overly morbid in this setting.", "generator_model": "claude-opus-4-5-20251101", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Thoracic Surgery", "abms_specialty": "Thoracic Surgery", "abms_source": "target_topic", "source_label_raw": "Thoracic Surgery", "source_quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129", "source_question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129-009", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/claude-opus-4-5-20251101/20251218T014545383Z_claude-opus-4-5-20251101_seed129", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251218T014545383Z_claude-opus-4-5-20251101_seed129.jsonl", "pred": "B", "model_outputs": "The patient presents with an early (postoperative day 8) post-pneumonectomy bronchopleural fistula (BPF) complicated by empyema. The presence of copious purulent sputum indicates that the infected pleural fluid is draining via the fistula into the remaining lung, posing a high risk of aspiration pneumonia and ARDS in the only functioning lung.\n\nManagement Priorities:\n1.  Protect the contralateral lung: Prevent aspiration of purulent material.\n2.  Drain the infection: Control the empyema.\n3.  stabilize the patient: Sepsis control.\n4.  Close the fistula: Eventually required, but timing and method depend on the condition of the tissues.\n\nEvaluation of Options:\n*   A. Immediate completion thoracoplasty with muscle flap coverage: Thoracoplasty is a major, disfiguring operation usually reserved for chronic empyema to obliterate the pleural space. Performing this immediately in an acutely ill patient with active gross infection is associated with high morbidity and is not the standard first-line management.\n*   B. Open window thoracostomy (Eloesser flap) with delayed stump repair: This is the most appropriate management strategy for a large BPF with empyema in the early postoperative period when immediate primary repair is hazardous due to poor tissue quality and active infection. The open window thoracostomy (OWT) provides effective, dependent drainage, prevents aspiration by preventing fluid accumulation and pressure buildup, and allows for local wound care (dressings/packing) to sterilize the cavity. Once the infection is cleared and the patient is optimized, delayed closure (e.g., via muscle flap like the Clagett maneuver) can be performed.\n*   C. Endoscopic stump closure with fibrin glue and covered stent placement: Endoscopic sealants are generally effective only for very small fistulas (< 3-5 mm). A 1.5 cm dehiscence is too large for glue. Stenting the main bronchial stump after pneumonectomy is technically challenging (risk of migration, obstruction of the remaining lung) and does not adequately address the empyema.\n*   D. Chest tube drainage with broad-spectrum antibiotics and observation: While chest tube drainage is the immediate emergency step to decompress the chest, it is not a sufficient \"management strategy\" for a 1.5 cm bronchial dehiscence. Spontaneous closure is highly unlikely, and a simple tube may clog or fail to adequately drain the thick empyema or manage the massive air leak, leaving the patient at risk.\n*   E. Transsternal transpericardial bronchial stump re-closure: This approach allows for stump closure in a clean tissue plane and is an excellent option for chronic fistulas or after the pleural space has been managed. However, in the acute setting with active empyema, the priority is drainage and control of the infected space. Simply closing the stump via a transsternal route does not treat the empyema, which requires open drainage (OWT) or potentially complex management. OWT is the standard \"bail-out\" for the septic complication described.\n\nTherefore, creating an open window (Eloesser flap) to control the fistula and empyema, with a plan for delayed repair, is the standard of care.\n\nThe answer is (B)"}, {"quiz_id": "ABMS20260101_claude-opus-4-5-20251101_p02", "question_id": "ABMS20260101_claude-opus-4-5-20251101_p02-009", "question": "A 68-year-old man with a 6.2 cm infrarenal abdominal aortic aneurysm undergoes elective endovascular aneurysm repair (EVAR). The proximal neck is 11 mm in length with 45-degree angulation and 28 mm diameter. Intraoperative completion angiography shows a type Ia endoleak. Multiple ballooning of the proximal seal zone fails to resolve the endoleak. Which intervention is MOST appropriate at this time?", "options": ["Placement of a Palmaz stent at the proximal seal zone", "Deployment of endoanchors (HeliFlex) at the proximal neck", "Conversion to open surgical repair", "Placement of an aortic extension cuff with suprarenal fixation", "Completion of procedure with planned surveillance and secondary intervention"], "answer": "B", "answer_index": 1, "explanation": "Intraoperative type Ia endoleak in a hostile neck (short, angulated) that persists after ballooning requires immediate intervention. Endoanchors (EndoAnchors/HeliFlex) provide transmural fixation that can achieve seal in challenging anatomy and have demonstrated efficacy for intraoperative type Ia endoleaks. A Palmaz stent provides radial force but not fixation and may not address the angulation issue. An extension cuff would not help as the problem is at the existing proximal seal zone. Conversion to open repair is overly morbid when endovascular options remain. Leaving a type Ia endoleak risks continued aneurysm pressurization and rupture.", "generator_model": "claude-opus-4-5-20251101", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Vascular Surgery", "abms_specialty": "Vascular Surgery", "abms_source": "target_topic", "source_label_raw": "Vascular Surgery", "source_quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129", "source_question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129-010", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/claude-opus-4-5-20251101/20251218T014545383Z_claude-opus-4-5-20251101_seed129", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251218T014545383Z_claude-opus-4-5-20251101_seed129.jsonl", "pred": "A", "model_outputs": "The clinical scenario describes an intraoperative Type Ia endoleak after endovascular aneurysm repair (EVAR) in a patient with a short (11 mm) and wide (28 mm) proximal neck. Balloon angioplasty has failed to resolve the leak.\n\n1.  Type Ia endoleak: This is a failure of the seal at the proximal attachment site. It subjects the aneurysm sac to systemic pressure and carries a high risk of rupture. It must be corrected intraoperatively.\n2.  Anatomical Constraints: The proximal neck is 11 mm long. Most standard EVAR devices require a 10-15 mm sealing zone. It is reasonable to assume the main body of the graft was deployed just below the renal arteries to maximize the available seal.\n3.  Troubleshooting:\n    *   Ballooning: This is the first-line treatment to mold the graft to the aortic wall. It has failed.\n    *   Proximal Extension Cuff (Option D): An extension cuff requires a proximal landing zone to achieve a seal. Since the patient only has an 11 mm neck which is already covered by the main body (assuming optimal deployment), there is no remaining infrarenal neck to land a cuff without covering the renal arteries. Therefore, a standard extension cuff is generally not a viable option unless chimney/snorkel techniques are used (not listed) or the initial deployment was significantly too low (not stated).\n    *   Endoanchors (Option B): Use of endoanchors (e.g., Heli-FX) is an option to tack the graft to the wall and can treat Type Ia endoleaks. However, they are often used to prevent migration or treat leaks associated with neck dilation. While a valid modern consideration, the classic and often preferred method to resolve a leak caused by insufficient radial force or graft folds (gutters) after ballooning is a balloon-expandable stent.\n    *   Open Conversion (C): This is the last resort if endovascular salvage fails.\n    *   Palmaz Stent (Option A): Placement of a large, balloon-expandable stent (such as a Palmaz stent) inside the proximal portion of the stent-graft is the standard \"bailout\" maneuver for a Type Ia endoleak that persists after balloon molding, especially when there is no land for a proximal extension. The Palmaz stent provides high radial force to crush graft folds, eliminate gutters, and improve the apposition of the graft fabric against the aortic wall.\n\nGiven the short neck preventing proximal extension, and the failure of molding, increasing the radial force with a Palmaz stent is the most appropriate next step.\n\nThe answer is (A)"}, {"quiz_id": "ABMS20260101_claude-opus-4-5-20251101_p02", "question_id": "ABMS20260101_claude-opus-4-5-20251101_p02-010", "question": "A 58-year-old woman with hypertrophic cardiomyopathy presents with recurrent syncope despite maximum-dose beta-blocker therapy. Echocardiography reveals a resting left ventricular outflow tract (LVOT) gradient of 85 mmHg, systolic anterior motion of the mitral valve, and septal thickness of 22 mm. Coronary angiography shows a large first septal perforator arising from the left anterior descending artery supplying the basal septum. She is referred for alcohol septal ablation. During the procedure, after balloon occlusion of the septal perforator and injection of echocardiographic contrast, opacification is noted in the papillary muscle region in addition to the target septal area. What is the most appropriate next step?", "options": ["Proceed with alcohol injection as planned given adequate septal opacification", "Abort the procedure and refer for surgical myectomy", "Advance the balloon more distally and reassess contrast distribution", "Reduce the planned alcohol volume by 50% and proceed", "Switch to a different septal perforator branch if available"], "answer": "C", "answer_index": 2, "explanation": "Papillary muscle opacification during alcohol septal ablation indicates that alcohol injection would cause papillary muscle necrosis, potentially resulting in severe mitral regurgitation. The appropriate step is to reposition the balloon more distally to exclude the branch supplying the papillary muscle. Proceeding with injection (A) or reducing volume (D) risks catastrophic mitral regurgitation. Aborting immediately (B) is premature before attempting repositioning. Switching perforators (E) may be considered only if repositioning fails and another suitable branch exists.", "generator_model": "claude-opus-4-5-20251101", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Cardiovascular", "abms_specialty": "Cardiovascular", "abms_source": "topics_mapped", "source_label_raw": "cardiology", "source_quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed123", "source_question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed123-001", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/claude-opus-4-5-20251101/20251129T135352000Z_claude-opus-4-5-20251101_seed123", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251129T135352000Z_claude-opus-4-5-20251101_seed123.jsonl", "pred": "C", "model_outputs": "This patient with symptomatic obstructive hypertrophic cardiomyopathy (HCM) is undergoing alcohol septal ablation. Myocardial contrast echocardiography (MCE) is a mandatory step prior to alcohol injection to define the vascular territory of the septal perforator and ensure no \"off-target\" embolization occurs.\n\nIn this scenario, MCE shows opacification of the papillary muscle in addition to the target septum. Injecting alcohol when the papillary muscle is opacified carries a high risk of papillary muscle infarction, which can lead to rupture or severe acute mitral regurgitation, a life-threatening complication. Therefore, proceeding with the injection as planned (Option A) or just reducing the volume (Option D) is contraindicated.\n\nThe finding indicates that a branch supplying the papillary muscle arises from the septal perforator distal to the current balloon position (since the injection is made through the balloon catheter lumen into the vessel distal to the balloon). The most appropriate *intra-procedural* troubleshooting step is to attempt to exclude the branch supplying the papillary muscle while still targeting the basal septum. This is done by advancing the balloon catheter more distally into the septal perforator. If the balloon can be placed distal to the origin of the papillary muscle branch but proximal to the branches supplying the hypertrophied basal septum, the procedure can continue safely.\n\nAfter repositioning, MCE must be repeated (\"reassess contrast distribution\") to confirm that the papillary muscle acts as \"negative\" (no contrast) and the target septum is still adequately perfused. If repositioning fails to exclude the papillary muscle or results in loss of coverage of the target basal septum, then switching to another vessel (Option E) or aborting for surgery (Option B) would be considered. However, attempting to salvage the optimal target vessel by repositioning is the standard immediate next step.\n\nThe answer is (C)"}]